All In MedTech

Device Trial Radar · NCT06112093

Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches

Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Oct 23, 2023

Primary completion

Oct 23, 2028

Study completion Oct 23, 2028

Sponsor

Lead sponsor
State University of New York - Upstate Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 1, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.

Conditions

  • Brain Concussion
  • Mild Traumatic Brain Injury
  • Headache
  • Post-Concussion Symptoms

Interventions

  • Repetitive Transcranial Magnetic StimulationDevice

    rTMS will be used to regulate the motor cortex to reduce headaches and post-concussion symptoms.

  • Sham Repetitive Transcranial Magnetic StimulationDevice

    Sham rTMS will be delivered by a sham coil as a comparator to the (active) rTMS. Sham rTMS will not change the brain function of the control group.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Daily headache diaryTime frame: daily documentation throughout the treatment course (4 weeks)
  2. Patient-Reported Outcomes Measurement Information System (PROMIS)Time frame: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up
  3. Protein expressionTime frame: baseline, immediately post-treatment (completion of rTMS)

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SUNY Upstate Medical University

    Syracuse, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.